Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Owen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hemodialysis International. International Symposium on Home Hemodialysis|May 28, 2009
Myocardial contractile function and intradialytic hypotensionPaul J Owen, William S Priestman, Mhairi K Sigrist, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 20, 2011
The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney diseaseStephen G John, Paul J Owen, Laura E A Harrison, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 2011
Benefits of regular walking exercise in advanced pre-dialysis chronic kidney diseaseGeorge C Kosmadakis, Stephen G John, Emma L Clapp, et al.
Plos Pathogens|August 4, 2009
Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c miceRoy R Chaudhuri, Sarah E Peters, Stephen J Pleasance, et al.
BMC Genomics|July 3, 2009
Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH)Roy R Chaudhuri, Andrew G Allen, Paul J Owen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2010
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney diseaseChristopher W McIntyre, Laura E A Harrison, M Tarek Eldehni, et al.
Journal of Medicinal Chemistry|August 11, 2012
3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3Stephen M F Jamieson, Darby G Brooke, Daniel Heinrich, et al.
European Journal of Applied Physiology|April 18, 2013
Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expressionEmma L Watson, George C Kosmadakis, Alice C Smith, et al.
European Journal of Medicinal Chemistry|June 19, 2019
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4Stephanie M Myers, Duncan C Miller, Lauren Molyneux, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hemodialysis International. International Symposium on Home Hemodialysis|May 28, 2009
Myocardial contractile function and intradialytic hypotensionPaul J Owen, William S Priestman, Mhairi K Sigrist, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 20, 2011
The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney diseaseStephen G John, Paul J Owen, Laura E A Harrison, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 2011
Benefits of regular walking exercise in advanced pre-dialysis chronic kidney diseaseGeorge C Kosmadakis, Stephen G John, Emma L Clapp, et al.
Plos Pathogens|August 4, 2009
Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c miceRoy R Chaudhuri, Sarah E Peters, Stephen J Pleasance, et al.
BMC Genomics|July 3, 2009
Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH)Roy R Chaudhuri, Andrew G Allen, Paul J Owen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2010
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney diseaseChristopher W McIntyre, Laura E A Harrison, M Tarek Eldehni, et al.
Journal of Medicinal Chemistry|August 11, 2012
3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3Stephen M F Jamieson, Darby G Brooke, Daniel Heinrich, et al.
European Journal of Applied Physiology|April 18, 2013
Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expressionEmma L Watson, George C Kosmadakis, Alice C Smith, et al.
European Journal of Medicinal Chemistry|June 19, 2019
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4Stephanie M Myers, Duncan C Miller, Lauren Molyneux, et al.
Pageof 1